# Randomized Study Using SM-030 Gel for Adults With Melasma

> **NCT06454747** · PHASE2 · RECRUITING · sponsor: **DermBiont, Inc.** · enrollment: 138 (estimated)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** SM-030 gel 0.64%
- **DRUG:** Placebo gel
- **DRUG:** SM-030 gel 0.08%

## Key facts

- **NCT ID:** NCT06454747
- **Lead sponsor:** DermBiont, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-27
- **Primary completion:** 2025-04
- **Final completion:** 2025-10
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454747, "Randomized Study Using SM-030 Gel for Adults With Melasma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06454747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*